These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7478583)

  • 1. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation.
    Malik KT; Wallace JI; Ivins SM; Brown KW
    Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Wilms' tumour suppressor (WT1) gene by an antisense RNA: a link with genomic imprinting?
    Ward A; Dutton JR
    J Pathol; 1998 Aug; 185(4):342-4. PubMed ID: 9828831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1.
    Eccles MR; Grubb G; Ogawa O; Szeto J; Reeve AE
    Oncogene; 1994 Jul; 9(7):2059-63. PubMed ID: 8208551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro.
    Moorwood K; Charles AK; Salpekar A; Wallace JI; Brown KW; Malik K
    J Pathol; 1998 Aug; 185(4):352-9. PubMed ID: 9828833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
    Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus.
    Campbell CE; Huang A; Gurney AL; Kessler PM; Hewitt JA; Williams BR
    Oncogene; 1994 Feb; 9(2):583-95. PubMed ID: 8290269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.
    Li RS; Law GL; Seifert RA; Romaniuk PJ; Morris DR
    Exp Cell Res; 1999 Feb; 247(1):257-66. PubMed ID: 10047468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.
    Warnecke C; Willich T; Holzmeister J; Bottari SP; Fleck E; Regitz-Zagrosek V
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):17-24. PubMed ID: 10229654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
    McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
    Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the transcriptional regulatory region of the human WT1 gene.
    Hofmann W; Royer HD; Drechsler M; Schneider S; Royer-Pokora B
    Oncogene; 1993 Nov; 8(11):3123-32. PubMed ID: 8414514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
    Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the WT1 tumor suppressor gene promoter by Pea3.
    Discenza MT; Vaz D; Hassell JA; Pelletier J
    FEBS Lett; 2004 Feb; 560(1-3):183-91. PubMed ID: 14988020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CART gene promoter transcription is regulated by a cyclic adenosine monophosphate response element.
    Barrett P; Davidson J; Morgan P
    Obes Res; 2002 Dec; 10(12):1291-8. PubMed ID: 12490674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
    Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
    Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.